Bertelli R, Varotti G, Puviani L, Cavallari G, Pacilè V, Prezzi D, Tsivian M, Neri F, D'Arcangelo G Liviano, Mosconi G, Stefoni S, Fuga G, Faenza A, Nardo B
Department of Surgery, Intensive Care Unit and Transplantations, S Orsola Hospital, University of Bologna, Bologna, Italy.
Transplant Proc. 2007 Jul-Aug;39(6):1833-4. doi: 10.1016/j.transproceed.2007.05.057.
Double-kidney transplantation is performed using organs from marginal donors with a histological score not suitable for single kidney transplantation. The aim of this study was to verify the results obtained with double-kidney transplantation in terms of graft/patient survivals and complications.
Between September 2001 and September 2006. 26 double-kidney transplantations were performed in our center. Indications for surgery were: chronic glomerulonephritis (n = 17), polycystic disease (n = 4), reflux nephropathy (n = 1), hypertensive nephroangiosclerosis (n = 4). The kidneys were all perfused with Celsior solution and mean cold ischemia time was 16.7 +/- 2.5 hours. In all cases, a pretransplant kidney biopsy was performed to evaluate the damage (mean score: 4.3). Immunosuppression was tacrolimus-based for all patients.
Eighteen patients had good renal postoperative function, while the other eight displayed acute tubular necrosis. Two of the patients who had severe acute tubular necrosis never recovered renal function. There was only one episode of acute rejection, while the incidence of urinary complications was 31%. There were two surgical reoperations for intestinal perforation. Graft and recipient survivals were 82.7% and 100%, and 78.9% and 94% at 3 and 36 months, respectively.
Double-kidney transplantation is a safe strategy to face the organ shortage. The score used in this study is useful to determine whether a kidney should be refused or suitable for single- or dual-kidney transplantation. The results of our experience are encouraging, but the series is too small to allow a conclusion.
双肾移植使用的是来自边缘供体的器官,其组织学评分不适合单肾移植。本研究的目的是验证双肾移植在移植物/患者存活率及并发症方面所取得的结果。
2001年9月至2006年9月期间,我们中心进行了26例双肾移植手术。手术指征为:慢性肾小球肾炎(n = 17)、多囊肾病(n = 4)、反流性肾病(n = 1)、高血压性肾血管硬化(n = 4)。所有肾脏均用赛而斯欧液灌注,平均冷缺血时间为16.7±2.5小时。所有病例均在移植前进行肾活检以评估损伤情况(平均评分:4.3)。所有患者均采用以他克莫司为基础的免疫抑制方案。
18例患者术后肾功能良好,另外8例出现急性肾小管坏死。其中2例严重急性肾小管坏死患者肾功能未恢复。仅发生1次急性排斥反应,而泌尿系统并发症的发生率为31%。因肠穿孔进行了2次手术再干预。3个月和36个月时的移植物存活率分别为82.7%和78.9%,患者存活率分别为100%和94%。
双肾移植是应对器官短缺的一种安全策略。本研究中使用的评分有助于确定一个肾脏是否应被拒绝或适合单肾移植或双肾移植。我们的经验结果令人鼓舞,但病例系列过小,无法得出结论。